Trial Profile
Clinical Effect of Rebamipide on Chronic Gastritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Gastritis
- Focus Therapeutic Use
- 21 Sep 2015 Planned number of patients changed to 180.
- 14 Sep 2015 Results published in the Clinical Drug Investigation.
- 23 Mar 2015 New trial record